Q2 2011

Filed Jan 14, 2011 · 10-Q · 45 days after period end · 0001019687-11-000179

Q2 2011 · 10-Q

Revenue—

Net Income

-$1.50M

no prior Q2 2010 on file

EPS, diluted—

Gross Profit-$1,114—

Operating Income-$1,742,039—

Same quarter

no prior Q2 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Nov 30, 2010 · filed Jan 14, 2011 · 45 d after period end

Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR